This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...
Novo Nordisk is seeking up to $830 million in damages from KBP Biosciences, according to a ruling by a Singapore court, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback